Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori

被引：36

作者：

Tanaka, M

Isogai, E

Isogai, H

Hayashi, S

Hirose, K

Kimura, K

Sugiyama, T

Sato, K

机构：

[1] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 1, Edogawa Ku, Tokyo 1348630, Japan

[2] Hlth Sci Univ Hokkaido, Dept Prevent Dent, Ishikari, Hokkaido, Japan

[3] Sapporo Med Univ, Div Anim Experimentat, Sapporo, Hokkaido, Japan

[4] Jichi Med Univ, Dept Microbiol, Minami Kawachi, Tochigi, Japan

[5] Hokkaido Inst Technol, Sapporo, Hokkaido, Japan

[6] Hokkaido Univ, Dept Internal Med 3, Sch Med, Sapporo, Hokkaido 060, Japan

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 06期

关键词：

D O I：

10.1093/jac/dkf055

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1039 / 1040A

页数：2

共 6 条

[1]

Adamsson I, 2000, J CHEMOTHERAPY, V12, P5

[2] Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection [J].

Cammarota, G ;

Cianci, R ;

Cannizzaro, O ;

Cuoco, L ;

Pirozzi, G ;

Gasbarrini, A ;

Armuzzi, A ;

Zocco, MA ;

Santarelli, L ;

Arancio, F ;

Gasbarrini, G .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) :1339-1343

[3]

Ellenrieder V, 1999, SCAND J GASTROENTERO, V34, P750, DOI 10.1080/003655299750025660

[4]

Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P695

[5]

Ling T K, 1996, Helicobacter, V1, P57, DOI 10.1111/j.1523-5378.1996.tb00009.x

[6] Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones [J].

Sánchez, JEG ;

Sáenz, NG ;

Rincón, MR ;

Martín, IT ;

Sánchez, EG ;

Martínez, MJF .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :283-285

← 1 →